Project Details
| Status | Active |
|---|---|
| Effective start/end date | 23/02/26 → 22/02/31 |
Clinical Trial Phase
- Phase III (a & b)
- External Sponsor
A Phase 3, Randomized, Double-blind, Placebo-controlled, 3-Part Study to Evaluate the Efficacy and Safety of Orally Administered Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-demand Treatment of Angioedema Attacks in Adults with Acquired Angioedema due to C1 Inhibitor Deficiency
- Fok, Jason (Primary Chief Investigator (PCI))
Project: Research